PLATINUM-SENSITIVE OVARIAN CARCINOMA
Clinical trials for PLATINUM-SENSITIVE OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-SENSITIVE OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for PLATINUM-SENSITIVE OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to shrink ovarian tumors in recurrent cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (CDX-1140) to a standard immunotherapy combo (pembrolizumab and bevacizumab) can shrink tumors in people with ovarian cancer that has returned. About 80 adults with recurrent ovarian, fallopian tube, or peritoneal cancer will r…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Can switching PARP inhibitors outsmart cancer? new trial aims to find out
Disease control Recruiting nowThis study is testing a drug called talazoparib in people with advanced solid tumors that have specific DNA repair gene mutations. The goal is to see if this PARP inhibitor can shrink tumors or slow their growth, even in patients who have already tried a similar drug. About 36 ad…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:48 UTC